John William Jacobs

National Penn Bancshares, Inc. operates as a bank holding company, which provides financial and banking services through its subsidiary, National Penn Bank. It operates through the Community Banking and Other segment. The Community Banking segment provides commercial banking and consumer banking services, including deposit accounts, demand, NOW, money market, other checking and savings accounts and certificates of deposits. The Other segment includes wealth management where commercial and consumer banking operations, including mortgage lending services are provided. Its consumer loan products include installment loans, home equity loans, residential mortgage loans, multi-family loans, educational loans and credit cards. The company was founded in January 1982 and is headquartered in Allentown, PA.

Venturis Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the developing protein drug candidates to address diseases such as diabetic wounds, severe coronary heart disease and peripheral artery disease. The company develops injectable and topical formulations of its active pharmacological ingredient to facilitate the growth of new blood vessels in the heart, tissues and organs. It focuses on developing protein drug candidates to be used in the treatment of cardiovascular disease. CardioVascular BioTherapeutics was founded by Daniel C. Montano, Thomas J. Stegmann and Grant Gordon in March 1998 and is headquartered in Dallas, TX.

Phage Biotechnology Corp. manufactures protein pharmaceuticals including pegylated human growth hormone, pegylated G-CSF, pegylated interferon alpha, beta interferon, and single-chain antibodies. It also develops biopharmaceuticals whose patents expire. The company was founded in 1998 and is headquartered in Las Vegas, NV.